Karolinska Study Links 250+ Proteins to Malaria Outcomes
Researchers identified 250+ proteins linked to malaria severity, offering faster risk prediction and treatment.
Summary
Karolinska Institutet scientists identified over 250 blood proteins altered by malaria, offering insight into disease severity. The study followed 72 adults and revealed protein signatures that could predict which patients are most at risk. This discovery may support earlier, more targeted treatment for life-threatening malaria infections.
Key Takeaways
- Over 250 proteins were strongly affected by malaria infection.
- These proteins help predict disease severity in early stages.
- The findings may lead to faster, targeted care for high-risk patients.
Researchers at Karolinska Institutet have identified over 250 proteins that are strongly affected by malaria, which could help predict the severity of the disease and thus enable faster treatment for the most critical patients.
The study, published in the journal Immunity, was conducted on 72 adult travellers diagnosed with malaria at Karolinska University Hospital after returning from tropical regions.
By analysing blood samples from these individuals, who were followed for a year, the researchers were able to identify around 700 proteins that changed during the infection, of which over 250 were strongly affected. In this way, the researchers were able to map proteins in the blood, which made it possible, among other things, to group patients according to the severity of the disease.
"Malaria can quickly become life-threatening, but it is difficult to predict at an early stage which patients are at risk of deterioration. Our results show how a set of proteins can help identify high-risk patients more quickly and enable more effective treatment," says Anna Färnert, professor at the Department of Medicine, Solna, Karolinska Institutet, and senior physician at Karolinska University Hospital, who led the study together with Christopher Sundling at the same institution.
Through data-driven analysis, the researchers were able to link the proteins to specific immune cells and identify the organs from which the proteins originate.
‘In this study, we have been able to measure such a large number of proteins with high precision in the blood of malaria patients for the first time. This provides completely new and detailed insights into the immune system's response to the infection,’ says first author Maximilian Julius Lautenbach, postdoctoral researcher at the Department of Medicine, Solna, Karolinska Institutet.
The researchers emphasise that further studies are needed to validate these findings in larger patient groups and to explore the potential clinical applications of the protein signatures.
Reference: Motso A, Pelcman B, Kalinovich A, et al. GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity. Cell. 2025. doi: 10.1016/j.cell.2025.05.042
This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source. Our press release publishing policy can be accessed here.
This content includes text that has been generated with the assistance of AI. Technology Networks' AI policy can be found here.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
